CLINT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.321800E-01
Normal-vs-Stage2
6.392800E-01
Normal-vs-Stage3
2.017000E-01
Normal-vs-Stage4
2.806000E-01
Stage1-vs-Stage2
6.281000E-01
Stage1-vs-Stage3
1.729160E-01
Stage1-vs-Stage4
6.881000E-01
Stage2-vs-Stage3
1.407010E-01
Stage2-vs-Stage4
3.162600E-01
Stage3-vs-Stage4
7.140400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.404600E-01
Normal-vs-AfricanAmerican
9.241200E-01
Normal-vs-Asian
5.801400E-01
Caucasian-vs-AfricanAmerican
7.444000E-01
Caucasian-vs-Asian
4.697200E-01
AfricanAmerican-vs-Asian
4.988800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.526800E-01
Normal-vs-Female
7.882200E-01
Male-vs-Female
4.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.624200E-01
Normal-vs-Age(41-60Yrs)
5.208000E-01
Normal-vs-Age(61-80Yrs)
7.990000E-01
Normal-vs-Age(81-100Yrs)
8.986400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.549600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.372400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.321400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.454410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.775200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.414400E-01
Normal-vs-Daily Drinker
9.510200E-01
Normal-vs-Weekly Drinker
9.659400E-01
Normal-vs-Occasional Drinker
4.205200E-01
Normal-vs-Social Drinker
6.172000E-01
Non Drinker-vs-Daily Drinker
3.953400E-01
Non Drinker-vs-Weekly Drinker
6.489000E-01
Non Drinker-vs-Occasional Drinker
4.704600E-01
Non Drinker-vs-Social Drinker
8.777000E-01
Daily Drinker-vs-Weekly Drinker
8.569400E-01
Daily Drinker-vs-Occasional Drinker
1.106160E-01
Daily Drinker-vs-Social Drinker
4.386400E-01
Weekly Drinker-vs-Occasional Drinker
3.281200E-01
Weekly Drinker-vs-Social Drinker
7.308000E-01
Occasional Drinker-vs-Social Drinker
3.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.109600E-02
Normal-vs-Grade 2
2.057900E-02
Normal-vs-Grade 3
2.346200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.780000E-02
Grade 1-vs-Grade 3
1.401870E-02
Grade 1-vs-Grade 4
7.109600E-02
Grade 2-vs-Grade 3
3.401200E-01
Grade 2-vs-Grade 4
2.057900E-02
Grade 3-vs-Grade 4
2.346200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.505000E-01
Normal-vs-NonDiabetic
7.022800E-01
Diabetic-vs-NonDiabetic
3.713800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.455800E-01
Normal-vs-NoPancreatitis
7.910600E-01
Pancreatitis-vs-NoPancreatitis
5.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.185800E-01
Normal-vs-N1
6.710600E-01
N0-vs-N1
9.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.843400E-01
Normal-vs-TP53-NonMutant
5.369400E-01
TP53-Mutant-vs-TP53-NonMutant
5.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
